5hkz - Revision history

OCA at 10:45, 16 August 2023

OCA — Wed, 16 Aug 2023 10:45:29 GMT

←Older revision		Revision as of 10:45, 16 August 2023
Line 3:		Line 3:
	<StructureSection load='5hkz' size='340' side='right'caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='5hkz' size='340' side='right'caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat"~~><scene name~~=~~'pdbligand=NA:SODIUM+ION'>NA</scene~~></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.8Å</td></tr>
-	<tr id='~~NonStdRes~~'><td class="sblockLbl"><b>[[~~Non-Standard_Residue~~\|~~NonStd Res~~:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=~~PTR~~:~~O-PHOSPHOTYROSINE~~'>~~PTR~~</scene><~~/td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene></td></tr>
-	~~<tr id~~='~~related'><td class~~=~~"sblockLbl"><b>[[Related_structure\|Related~~:~~]]</b></td><td class="sblockDat">[[5hl0\|5hl0]], [[5hkw\|5hkw]], [[5hkx\|5hkx]], [[5hky\|5hky]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5hkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hkz OCA], [https://pdbe.org/5hkz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5hkz RCSB], [https://www.ebi.ac.uk/pdbsum/5hkz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5hkz ProSAT]</span></td></tr>
-	~~<tr id='gene~~'>~~<td class="sblockLbl"><b>[[Gene\|Gene:]]~~</b>~~</td><td class="sblockDat">CBL, CBL2, RNF55 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])~~</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5hkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hkz OCA], [~~http~~://pdbe.org/5hkz PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5hkz RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5hkz PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5hkz ProSAT]</span></td></tr>	+
	</table>		</table>
	== Disease ==		== Disease ==
-	[~~[http~~://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN]] Defects in CBL are the cause of Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:[~~http~~://omim.org/entry/613563 613563]]. A syndrome characterized by a phenotype reminiscent of Noonan syndrome. Clinical features are highly variable, including facial dysmorphism, short neck, developmental delay, hyperextensible joints and thorax abnormalities with widely spaced nipples. The facial features consist of triangular face with hypertelorism, large low-set ears, ptosis, and flat nasal bridge. Some patients manifest cardiac defects.<ref>PMID:20619386</ref>	+	[https://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN] Defects in CBL are the cause of Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:[https://omim.org/entry/613563 613563]. A syndrome characterized by a phenotype reminiscent of Noonan syndrome. Clinical features are highly variable, including facial dysmorphism, short neck, developmental delay, hyperextensible joints and thorax abnormalities with widely spaced nipples. The facial features consist of triangular face with hypertelorism, large low-set ears, ptosis, and flat nasal bridge. Some patients manifest cardiac defects.<ref>PMID:20619386</ref>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN]] Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function.<ref>PMID:10514377</ref> <ref>PMID:11896602</ref> <ref>PMID:14739300</ref> <ref>PMID:15190072</ref> <ref>PMID:17509076</ref> <ref>PMID:18374639</ref> <ref>PMID:19689429</ref> <ref>PMID:21596750</ref> [[http://www.uniprot.org/uniprot/SPY2_HUMAN SPY2_HUMAN]] May function as an antagonist of fibroblast growth factor (FGF) pathways and may negatively modulate respiratory organogenesis.<ref>PMID:10887178</ref>	+	[https://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN] Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function.<ref>PMID:10514377</ref> <ref>PMID:11896602</ref> <ref>PMID:14739300</ref> <ref>PMID:15190072</ref> <ref>PMID:17509076</ref> <ref>PMID:18374639</ref> <ref>PMID:19689429</ref> <ref>PMID:21596750</ref>
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Battaile~~, K P~~]]	+	[[Category: Battaile KP]]
-	[[Category: Cooper, A]]	+	[[Category: Cooper A]]
-	[[Category: Gao, P]]	+	[[Category: Gao P]]
-	[[Category: Lovell, S]]	+	[[Category: Lovell S]]
-	[[Category: Mehzabeen, N]]	+	[[Category: Mehzabeen N]]
-	[[Category: Perez~~, R P~~]]	+	[[Category: Perez RP]]
-	[[Category: Zhang, N]]	+	[[Category: Zhang N]]
-	~~[[Category: Anticancer target]]~~	+
-	~~[[Category: Cbl]]~~	+
-	~~[[Category: Ligase]]~~	+
-	~~[[Category: Protein-protein interaction]]~~	+
-	~~[[Category: Spry2~~]]	+

OCA at 11:42, 25 December 2019

OCA — Wed, 25 Dec 2019 11:42:14 GMT

←Older revision		Revision as of 11:42, 25 December 2019
Line 1:		Line 1:

	==Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)==		==Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)==
-	<StructureSection load='5hkz' size='340' side='right' caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>	+	<StructureSection load='5hkz' size='340' side='right'caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>		<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>
Line 19:		Line 19:
	</StructureSection>		</StructureSection>
	[[Category: Human]]		[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Battaile, K P]]		[[Category: Battaile, K P]]
	[[Category: Cooper, A]]		[[Category: Cooper, A]]

OCA at 17:24, 15 November 2017

OCA — Wed, 15 Nov 2017 17:24:23 GMT

←Older revision		Revision as of 17:24, 15 November 2017
Line 3:		Line 3:
	<StructureSection load='5hkz' size='340' side='right' caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='5hkz' size='340' side='right' caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5hl0\|5hl0]], [[5hkw\|5hkw]], [[5hkx\|5hkx]], [[5hky\|5hky]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5hl0\|5hl0]], [[5hkw\|5hkw]], [[5hkx\|5hkx]], [[5hky\|5hky]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CBL, CBL2, RNF55 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5hkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hkz OCA], [http://pdbe.org/5hkz PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5hkz RCSB], [http://www.ebi.ac.uk/pdbsum/5hkz PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5hkz ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5hkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hkz OCA], [http://pdbe.org/5hkz PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5hkz RCSB], [http://www.ebi.ac.uk/pdbsum/5hkz PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5hkz ProSAT]</span></td></tr>
	</table>		</table>
Line 17:		Line 18:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Battaile, K P]]		[[Category: Battaile, K P]]
	[[Category: Cooper, A]]		[[Category: Cooper, A]]

OCA at 00:42, 19 January 2017

OCA — Thu, 19 Jan 2017 00:42:07 GMT

←Older revision		Revision as of 00:42, 19 January 2017
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5hkz is ~~ON HOLD until Paper Publication~~	+	==Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)==
-		+	<StructureSection load='5hkz' size='340' side='right' caption='[[5hkz]], [[Resolution\|resolution]] 1.80Å' scene=''>
-	~~Authors~~: ~~Lovell~~, S., ~~Battaile~~, K.P., ~~Mehzabeen~~, N., ~~Zhang~~, N., ~~Cooper,~~ A., ~~Gao~~, P., ~~Perez~~, R.P.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5hkz]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HKZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5HKZ FirstGlance]. <br>
-	~~Description~~: ~~Crystal Structure~~ of c-~~Cbl TKBD in complex with SPRY2 peptide (36~~-60, ~~pY55) Refined~~ to 1.~~8 A Resolution (P21~~ form)	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5hl0\|5hl0]], [[5hkw\|5hkw]], [[5hkx\|5hkx]], [[5hky\|5hky]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5hkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hkz OCA], [http://pdbe.org/5hkz PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5hkz RCSB], [http://www.ebi.ac.uk/pdbsum/5hkz PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5hkz ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN]] Defects in CBL are the cause of Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:[http://omim.org/entry/613563 613563]]. A syndrome characterized by a phenotype reminiscent of Noonan syndrome. Clinical features are highly variable, including facial dysmorphism, short neck, developmental delay, hyperextensible joints and thorax abnormalities with widely spaced nipples. The facial features consist of triangular face with hypertelorism, large low-set ears, ptosis, and flat nasal bridge. Some patients manifest cardiac defects.<ref>PMID:20619386</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/CBL_HUMAN CBL_HUMAN]] Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function.<ref>PMID:10514377</ref> <ref>PMID:11896602</ref> <ref>PMID:14739300</ref> <ref>PMID:15190072</ref> <ref>PMID:17509076</ref> <ref>PMID:18374639</ref> <ref>PMID:19689429</ref> <ref>PMID:21596750</ref> [[http://www.uniprot.org/uniprot/SPY2_HUMAN SPY2_HUMAN]] May function as an antagonist of fibroblast growth factor (FGF) pathways and may negatively modulate respiratory organogenesis.<ref>PMID:10887178</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Battaile, K P]]
	[[Category: Cooper, A]]		[[Category: Cooper, A]]
	[[Category: Gao, P]]		[[Category: Gao, P]]
-	[[Category: Battaile, K.P]]
	[[Category: Lovell, S]]		[[Category: Lovell, S]]
		+	[[Category: Mehzabeen, N]]
		+	[[Category: Perez, R P]]
	[[Category: Zhang, N]]		[[Category: Zhang, N]]
-	[[Category: ~~Mehzabeen, N~~]]	+	[[Category: Anticancer target]]
-	[[Category: ~~Perez, R.P~~]]	+	[[Category: Cbl]]
		+	[[Category: Ligase]]
		+	[[Category: Protein-protein interaction]]
		+	[[Category: Spry2]]

OCA at 00:49, 28 January 2016

OCA — Thu, 28 Jan 2016 00:49:04 GMT

←Older revision		Revision as of 00:49, 28 January 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5hkz is ON HOLD	+	The entry 5hkz is ON HOLD until Paper Publication

-	Authors: Lovell, ~~Scott~~, Battaile, ~~Kevin~~ P., Mehzabeen, ~~Nurjahan~~, Zhang, Na, Cooper, ~~Anne~~, Gao, ~~Philip~~, Perez, ~~Raymond~~ P.	+	Authors: Lovell, S., Battaile, K.P., Mehzabeen, N., Zhang, N., Cooper, A., Gao, P., Perez, R.P.

	Description: Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)		Description: Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
-	[[Category: ~~Mehzabeen, Nurjahan, Zhang, Na,~~ Cooper, ~~Anne,~~ Gao, ~~Philip~~, ~~Perez, Raymond~~ P]]	+	[[Category: Cooper, A]]
-	[[Category: Lovell, ~~Scott~~, ~~Battaile~~, ~~Kevin~~ P]]	+	[[Category: Gao, P]]
		+	[[Category: Battaile, K.P]]
		+	[[Category: Lovell, S]]
		+	[[Category: Zhang, N]]
		+	[[Category: Mehzabeen, N]]
		+	[[Category: Perez, R.P]]

OCA: Protected "5hkz" [edit=sysop:move=sysop]

OCA — Wed, 20 Jan 2016 15:41:13 GMT

Protected "5hkz" [edit=sysop:move=sysop]

←Older revision

Revision as of 15:41, 20 January 2016

OCA: New page: '''Unreleased structure''' The entry 5hkz is ON HOLD Authors: Lovell, Scott, Battaile, Kevin P., Mehzabeen, Nurjahan, Zhang, Na, Cooper, Anne, Gao, Philip, Perez, Raymond P. Descriptio...

OCA — Wed, 20 Jan 2016 15:41:11 GMT

New page: '''Unreleased structure''' The entry 5hkz is ON HOLD Authors: Lovell, Scott, Battaile, Kevin P., Mehzabeen, Nurjahan, Zhang, Na, Cooper, Anne, Gao, Philip, Perez, Raymond P. Descriptio...

New page

'''Unreleased structure'''

The entry 5hkz is ON HOLD

Authors: Lovell, Scott, Battaile, Kevin P., Mehzabeen, Nurjahan, Zhang, Na, Cooper, Anne, Gao, Philip, Perez, Raymond P.

Description: Crystal Structure of c-Cbl TKBD in complex with SPRY2 peptide (36-60, pY55) Refined to 1.8 A Resolution (P21 form)
[[Category: Unreleased Structures]]
[[Category: Mehzabeen, Nurjahan, Zhang, Na, Cooper, Anne, Gao, Philip, Perez, Raymond P]]
[[Category: Lovell, Scott, Battaile, Kevin P]]